Description
Announcement of the listing and admission to dealings of equity shares of Sudeep Pharma Limited on BSE SME platform.
Summary
BSE has announced that the equity shares of Sudeep Pharma Limited will be listed and admitted to dealings on the BSE SME platform. The company has been assigned scrip code 544619, symbol SUDEEPPHRM, and ISIN number INE0QPI01025. The exact listing date and additional security details will be communicated through a separate notice.
Key Points
- Company Name: Sudeep Pharma Limited
- Scrip Code: 544619
- Trading Symbol: SUDEEPPHRM
- ISIN: INE0QPI01025
- Platform: BSE SME Segment
- Listing will occur in due course with date to be notified separately
Regulatory Changes
No regulatory changes introduced. This is a standard new listing notification.
Compliance Requirements
- Trading members should note the scrip details for future trading once listing date is announced
- No immediate action required until the listing date notice is issued
Important Dates
- Notice Date: November 27, 2025
- Listing Date: To be notified through separate notice
Impact Assessment
This announcement has limited immediate market impact as it is an informational notice about an upcoming SME listing. The actual listing date and price band details are pending. Trading members and investors interested in SME segment stocks should watch for the follow-up notice with specific listing date and security details. The impact is confined to the SME segment and relevant to investors seeking exposure to pharmaceutical sector SME companies.
Impact Justification
New SME listing announcement with specific scrip details but pending listing date. Medium importance for traders interested in new SME listings, low market-wide impact.